Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 33,986 | -51,892 | -19,164 | -33,714 | -39,049 |
| Depreciation Amortization | 1,281 | 1,538 | 1,358 | 969 | 455 |
| Accounts receivable | N/A | N/A | 39 | -39 | 206 |
| Other Working Capital | -2,735 | 1,823 | -537 | -171 | 234 |
| Other Operating Activity | -44,671 | 37,123 | 3,679 | 6,511 | 7,414 |
| Operating Cash Flow | $-12,139 | $-11,408 | $-14,625 | $-26,444 | $-30,741 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -16,300 | -5,400 |
| PPE Investments | -564 | -72 | -7 | -111 | -8,666 |
| Other Investing Activity | 0 | 0 | 0 | -1,666 | -113 |
| Investing Cash Flow | $-564 | $-72 | $-7 | $-18,077 | $-14,179 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,923 | 16,146 | 3,903 | 29 | 68,410 |
| Other Financing Activity | -844 | -1,352 | -375 | 21,129 | 521 |
| Financing Cash Flow | $12,079 | $14,795 | $3,528 | $21,158 | $68,931 |
| Beginning Cash Position | 8,209 | 4,895 | 15,998 | 50,321 | 26,310 |
| End Cash Position | 7,585 | 8,209 | 4,895 | 26,958 | 50,321 |
| Net Cash Flow | $-624 | $3,314 | $-11,104 | $-23,363 | $24,011 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,139 | -11,408 | -14,625 | -26,444 | -30,741 |
| Capital Expenditure | -564 | -72 | -7 | -111 | -8,668 |
| Free Cash Flow | -12,703 | -11,480 | -14,632 | -26,555 | -39,409 |